Oncolytics Biotech Inc T.ONC

ASCO buzz coming

[SundayMovies]

I am surprise that the ASCO buzzz hasn't started yet. 

Data optimism should start soon and rocket this baby to the moon. Space X watch out, this ONCY will blow you up. lol!

[Angler101]

I am far from being any kind of expert on anything to do with FDA , (or on anything else) so can anyone on this forum (ie. Notable) please tell us  what the chances are that we could see the accelerated approval of Pela before phase 3 trials get underway?

[KTDfyi]

That is the million dollar question, or in my situation multi million. They have to apply for a AA, then the FDA gets everything data wise. I know there are numbers out there for the probabilities. With 2 fast tracks, if the data is good? Waiting, all we can do. Wouldn't be surprised though, it's as safe as can be, major factor for the FDA, If BP steps in I can see a lot of action, the FDA

[Angler101]

If management is saying they can and will do something about the share price, I could see accelerated approval before ASCO being the perfect catalyst to make that happen....and what a slam-dunk that would be for a big pharma buyout!...woohooo!

[jimsenior]

Neither am I an expert, but it is a good question. AA would most likely come from PDAC or mBC.     Both now  have CPIs. So any chance of AA would seem to be a combo application. We would need the owners of the CPIs to file with us presumably. Perhaps those more knowlegeable can enlighten. The bottom line ,we are at the mercy of the markets. If there are those who do not

[westcoast1000]

Along with Jim senior I would expect an aa approval must hinge on the combo treatment. Such treatments involve a CPI and also perhaps chemo. So yes, I would think the application to the FDA must come from the companies participating. So I some sense, we need the selected partner to apply with us. It is a chicken-egg or principal-agent kind of situation. 

[Angler101]

Thank you both for your replies to that question. Yeah, it makes sense what you’re saying. So hopefully, the need for that collaboration will expedite the partnered application for approval along with the buyout we’re all waiting for.